Using Breath Tests to Study Gut Sulfur Changes During Dietary Therapy

Purpose To determine whether a short-term elemental diet followed by a reduced sulfur diet is a safe, tolerable, and effective non-pharmacologic strategy to improve clinical outcomes, reduce inflammation, and beneficially modulate the gut microbiome in adults with mild-to-moderate ulcerative colitis. A secondary purpose is to validate breath-based biomarkers as non-invasive tools to monitor sulfur metabolism and disease activity. Breath biomarkers include volatile organic compounds (VOCs) and exhaled breath condensate (EBC) to assess sulfur-related metabolites.

Hypothesis A 2-week elemental diet followed by a 10-week reduced sulfur diet will reduce intestinal inflammation and improve clinical outcomes by shifting the gut microbiome away from pro-inflammatory, sulfur-metabolizing bacteria, resulting in reduced sulfur metabolite production detectable through exhaled volatile organic compounds and exhaled breath condensate.

Justification Despite advances in biologic therapies, many UC patients fail to achieve sustained remission, and current treatments do not address upstream drivers such as diet-microbiome interactions. Elemental diets have demonstrated efficacy in Crohn's disease but remain understudied in UC. Emerging evidence links dietary sulfur, microbial sulfur metabolism, and toxic metabolites to UC pathogenesis. This study addresses critical gaps by testing a feasible dietary intervention and validating non-invasive breath biomarkers for real-time disease monitoring and precision nutrition.

Objectives

* Evaluate the clinical efficacy, safety, and feasibility of an elemental diet followed by an reduced sulfur diet. * Characterize changes in gut microbiome composition, inflammatory markers, and sulfur-related metabolic outputs. * Validate breath-based volatile organic compounds and exhaled breath condensate as biomarkers of sulfur metabolism and treatment response. * Identify microbial and metabolic signatures predictive of dietary response.

Research Design A prospective, randomized, controlled trial in adults with mild-to-moderate UC. All participants complete a 2-week elemental diet, followed by randomization (2:1) to either a reduced sulfur diet group (intervention group) or return to habitual diet group (control group) for 10 weeks. Clinical indices, inflammatory biomarkers, stool microbiome profiles and breath samples are collected longitudinally. The initial 2-week elemental diet is applied uniformly to standardize baseline microbial and metabolic conditions prior to randomization and does not replace or delay clinical care decisions.

Statistical Analysis Primary outcomes will be assessed using within- and between-group comparisons of clinical and biochemical response at week 12. Microbiome and metabolomic data will be analyzed using multivariate and differential abundance methods. Correlations between breath biomarkers, microbiome features, and clinical outcomes will assess sensitivity and specificity.

• Stool Biomarkers [Срок оценки: Baseline, week 2 and week 12]
• C-Reactive Protein (CRP) concentration [Срок оценки: Baseline, week 2 and week 12]
• Complete Blood Count (CBC) parameters [Срок оценки: Baseline, week 2 and week 12]
• Serum inflammatory biomarker concentrations [Срок оценки: Baseline, week 2 and week 12]
• Breath Biomarkers [Срок оценки: Baseline, week 2 and week 12]
• Adherence to the Elemental Diet and Reduced Sulfur Diet Intervention [Срок оценки: Baseline, week 2 and week 12]
• Change in Quality of Life [Срок оценки: Baseline, week 2 and week 12]
• Change in Anxiety [Срок оценки: Baseline, week 2 and week 12]
• Change in Depression [Срок оценки: Baseline, week 2 and week 12]
• Change in Weight [Срок оценки: Baseline, week 2 and week 12]
• Change in Body Mass Index (BMI) [Срок оценки: Baseline, week 2 and week 12]